What Drugs Should You Not Take With Alprazolam? FDA Drug Interaction Guide

Alprazolam should never be combined with strong CYP3A4 inhibitors like clarithromycin, ketoconazole, or itraconazole because these drugs can double or triple alprazolam levels in your blood, causing dangerous oversedation, respiratory depression, and overdose risk. The FDA classifies these combinations as contraindicated, meaning the risks outweigh any potential benefit. Additionally, combining alprazolam with opioids, certain antidepressants like fluoxetine, or other CNS depressants significantly increases the risk of respiratory failure and death.

What Alprazolam Is and How It Works

Alprazolam (brand name Xanax) is a short-acting benzodiazepine prescribed for anxiety disorders, panic disorder, and sometimes off-label for insomnia. It works by enhancing the inhibitory neurotransmitter GABA at the GABA(A) receptor in the central nervous system, which reduces electrical activity in the brain and produces a calming effect.

Alprazolam is metabolized almost entirely through the liver enzyme CYP3A4, which means any drug that inhibits this enzyme can slow alprazolam's breakdown and cause it to accumulate to toxic levels in the bloodstream. The drug has a short half-life of 6–12 hours in healthy adults, but when combined with CYP3A4 inhibitors, this can extend significantly, leading to prolonged sedation, confusion, impaired coordination, and respiratory depression.

Because alprazolam is so widely prescribed (over 60 million prescriptions annually in the United States), and because benzodiazepines are frequently combined with other medications for common conditions, drug interactions with alprazolam are clinically common and potentially life-threatening.

The Most Serious Interactions: Contraindicated Combinations

The FDA explicitly lists the following drug combinations as contraindicated with alprazolam, meaning they should be avoided entirely:

Strong CYP3A4 Inhibitors (Contraindicated)

Clarithromycin, Itraconazole, and Ketoconazole are the most critical contraindications. These are strong inhibitors of the CYP3A4 enzyme, the primary pathway by which your liver clears alprazolam from your body. When combined, alprazolam concentrations can increase 2–3 fold or more, creating a serious risk of:

• Profound sedation and loss of consciousness
• Respiratory depression (slowed or stopped breathing)
• Overdose and death
• Dangerous falls and injuries in elderly patients
• Memory impairment and cognitive decline

Clarithromycin is a macrolide antibiotic commonly prescribed for respiratory and skin infections. Ketoconazole and itraconazole are antifungal medications used to treat fungal infections of the nails, skin, and internal organs. Because infections requiring these antibiotics are common, patients taking alprazolam frequently face this contraindication in real clinical practice.

Pharmacological Mechanism: CYP3A4 Inhibition

Alprazolam undergoes oxidative metabolism in the liver through the cytochrome P450 CYP3A4 pathway. When a strong CYP3A4 inhibitor is present, it competes with alprazolam for the enzyme's active site, reducing the rate at which alprazolam is broken down. This causes alprazolam to accumulate in tissues and plasma, extending its half-life from 6–12 hours to potentially 24–48 hours or longer. At higher concentrations, alprazolam's CNS depressant effects become exaggerated and potentially toxic.

The effect is dose-dependent: even standard therapeutic doses of alprazolam can reach dangerous levels when combined with a strong CYP3A4 inhibitor. This is why dose reduction or complete discontinuation is necessary if such a combination cannot be avoided.

Antidepressants: Fluoxetine and Nefazodone (Contraindicated)

Fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI), is documented in the FDA drug label to increase alprazolam plasma concentrations and cause further psychomotor performance decrements (impaired thinking, coordination, and reaction time). Nefazodone is similarly contraindicated with alprazolam. Both of these antidepressants are inhibitors of CYP3A4 and other hepatic enzymes, reducing alprazolam clearance.

This interaction is particularly problematic because SSRIs like fluoxetine are often prescribed for anxiety and depression—the same conditions for which alprazolam is used. Patients and providers may assume the combination is safe, but the FDA explicitly warns against it.

Major Interactions Requiring Close Monitoring

Opioids (Major – Risk of Respiratory Depression and Death)

The combination of alprazolam with opioids like dihydrocodeine, hydrocodone, morphine, fentanyl, or methadone is classified as a major interaction with a black box warning from the FDA. Both drug classes are CNS depressants that work through different receptor mechanisms:

• Benzodiazepines (like alprazolam) enhance GABA(A)-mediated inhibition
• Opioids activate mu-opioid receptors and also depress respiration through brainstem chemoreceptor sites

When combined, these drugs produce additive respiratory depression. The result is impaired breathing that can progress to complete apnea, coma, and death. Between 2015 and 2022, over 16,000 opioid overdose deaths involved benzodiazepines, according to CDC data. Many of these involved alprazolam.

Patients on chronic opioid therapy (for chronic pain) who are also prescribed alprazolam face particular risk. If both medications are medically necessary, they require intensive monitoring, dose optimization, and consideration of alternative treatments.

Other CYP3A4 Inhibitors (Major Interactions)

Aprepitant and Fosaprepitant are moderate to strong CYP3A4 inhibitors used to prevent chemotherapy-induced nausea and vomiting. While not absolutely contraindicated like clarithromycin or ketoconazole, they significantly increase alprazolam exposure and carry a major interaction rating. Patients should be monitored closely for excessive sedation, and alprazolam dose reduction may be necessary.

Clinical Scenarios: Real-World Alprazolam Interactions

Scenario 1: A 64-Year-Old Woman with Anxiety and a Respiratory Infection

Maria is a 64-year-old woman with generalized anxiety disorder who has been stable on alprazolam 0.5 mg three times daily for two years. She develops a community-acquired pneumonia and her primary care doctor prescribes clarithromycin 500 mg twice daily for 7 days.

Within 24 hours of starting clarithromycin, Maria's daughter notices she is unusually drowsy, confused, and unsteady on her feet. Maria has difficulty staying awake and falls asleep multiple times during the day, even after sleeping 10 hours the previous night. Her daughter becomes concerned when Maria has difficulty waking her for dinner.

What happened: Clarithromycin is a strong CYP3A4 inhibitor that immediately began reducing alprazolam clearance. Alprazolam levels accumulated in Maria's blood, causing profound CNS depression. This is not a side effect or idiosyncrasy—it is a predictable, severe drug interaction listed as contraindicated in both the alprazolam and clarithromycin FDA labels.

What should have happened: Maria's doctor should have prescribed an alternative antibiotic without CYP3A4 inhibition, such as azithromycin or a respiratory fluoroquinolone (e.g., levofloxacin). Alternatively, if clarithromycin was truly necessary, Maria should have been instructed to temporarily discontinue alprazolam or reduce the dose to 0.25 mg once daily under careful supervision. The doctor should have screened the clarithromycin prescription against Maria's current medication list before dispensing.

Scenario 2: A 72-Year-Old Man on Multiple Medications Including Opioids

Robert is a 72-year-old man with chronic low back pain and anxiety. He takes morphine 15 mg twice daily for pain, alprazolam 0.25 mg twice daily for anxiety, and various other medications for hypertension and diabetes. His pain management doctor and psychiatrist are unaware that he is taking both medications.

One afternoon, Robert's wife finds him unresponsive in his recliner, breathing slowly and shallowly at a rate of 8 breaths per minute (normal is 12–20). She calls 911, and Robert is transported to the emergency department where he is treated with naloxone (Narcan) to reverse the opioid-induced respiratory depression. He requires intubation and ICU admission.

What happened: The combination of morphine and alprazolam produced additive CNS and respiratory depression. At his doses, Robert's respiratory drive was suppressed to a critically dangerous level. This interaction is among the most common causes of benzodiazepine-related deaths in the United States.

What should have happened: Robert's doctors should have communicated with each other, identified the dangerous combination, and either (1) eliminated the alprazolam in favor of alternative anxiety management, or (2) reduced both doses to the lowest effective levels with intensive monitoring and patient/caregiver education about overdose signs. A naloxone prescription should have been dispensed with the opioid, and Robert's wife should have been trained to recognize respiratory depression and use naloxone if needed.

Comprehensive List of Alprazolam Interactions by Severity

Contraindicated (Do Not Use):

• Clarithromycin – Strong CYP3A4 inhibitor; causes profound alprazolam accumulation and severe CNS depression
• Itraconazole – Strong CYP3A4 inhibitor; similar mechanism to ketoconazole
• Ketoconazole – Strong CYP3A4 inhibitor; FDA explicitly lists alprazolam as contraindicated
• Fluoxetine (Prozac) – CYP3A4 inhibitor; increases alprazolam concentrations and impairs psychomotor performance
• Fluoxetine Hydrochloride – Same as fluoxetine; FDA label warns of increased alprazolam levels
• Nefazodone – Antidepressant that inhibits alprazolam metabolism

Major (Serious Risk – Requires Careful Monitoring or Avoidance):

• Opioids (morphine, fentanyl, dihydrocodeine, methadone, hydrocodone, codeine) – Black box warning for combined respiratory depression; highest risk of death
• Aprepitant – Moderate CYP3A4 inhibitor; increases alprazolam exposure during 3-day regimen
• Fosaprepitant – IV form of aprepitant; same mechanism of CYP3A4 inhibition
• Ritonavir – Strong CYP3A4 inhibitor (HIV protease inhibitor); listed as contraindicated in alprazolam FDA label

Moderate Interactions to Monitor

Beyond the contraindicated and major interactions, alprazolam can interact with numerous other CNS depressants and CYP3A4 inhibitors at a moderate level of severity. These include:

• Other benzodiazepines (diazepam, lorazepam) – Additive CNS depression if combined
• Alcohol – Significant CNS depression and impaired judgment; increases fall risk and overdose risk
• Antihistamines (diphenhydramine, hydroxyzine) – Additive sedation
• Sedating antidepressants (tricyclic antidepressants, mirtazapine, trazodone) – Additive CNS depression
• Anticholinergics (diphenhydramine, atropine) – Potential for confusion, urinary retention
• Other CYP3A4 inhibitors (verapamil, diltiazem, erythromycin, grapefruit juice) – Moderate reduction in alprazolam clearance

These moderate interactions do not require automatic discontinuation but do require dose adjustment, careful monitoring, and provider awareness. Patients should always inform their doctor and pharmacist about all medications, supplements, and dietary substances before starting alprazolam.

What Patients Should Tell Their Doctor Before Starting Alprazolam

Before your doctor prescribes alprazolam, you must disclose:

• All current medications, including prescription, over-the-counter, and herbal supplements
• Any antibiotic prescriptions you may be expecting (especially macrolides like azithromycin or clarithromycin)
• Any antifungal medications you take or may need to take
• All opioid medications, whether for pain or cough
• All antidepressants, mood stabilizers, or other psychiatric medications
• Alcohol use and frequency
• Any history of substance use disorder or addiction
• Liver disease or kidney disease
• Sleep apnea or other respiratory conditions
• Pregnancy or plans to become pregnant (benzodiazepines are Category C or D and can cause dependence in the fetus)

Your pharmacist should also conduct a comprehensive drug interaction screening when you pick up alprazolam and again each time you pick up a new medication. Do not assume that different doctors know about each other's prescriptions.

What to Do If You Are Already Taking Alprazolam and Need Another Medication

If you are currently taking alprazolam and your doctor prescribes a new medication:

1. Ask your pharmacist to check for interactions before you leave the pharmacy
2. Inform the prescribing doctor that you take alprazolam and ask explicitly if the new drug is safe in combination
3. If an interaction is identified: Ask if there is an alternative medication without the interaction, or if your alprazolam dose needs to be adjusted
4. Do not stop alprazolam suddenly even if an interaction is discovered—benzodiazepine withdrawal can be dangerous. Work with your doctor on a tapering plan
5. Watch for warning signs of alprazolam overdose, including extreme drowsiness, confusion, slurred speech, loss of coordination, slow or difficult breathing, and loss of consciousness
6. If you experience these signs, call 911 or go to an emergency room immediately

Key Takeaways

• Alprazolam is contraindicated with strong CYP3A4 inhibitors (clarithromycin, itraconazole, ketoconazole, fluoxetine, nefazodone) because these drugs can double or triple alprazolam blood levels, causing life-threatening CNS depression and respiratory failure.
• The combination of alprazolam and opioids carries a black box warning and is the cause of thousands of overdose deaths annually in the United States due to additive respiratory depression.
• Always inform all your doctors and your pharmacist about alprazolam use before starting any new medication, especially antibiotics, antifungals, antiretrovirals, or pain medications.
• If an interaction is discovered, do not stop alprazolam abruptly—work with your doctor on a safe tapering plan or switch to an alternative treatment.
• Alcohol and other CNS depressants significantly increase the risk of overdose when combined with alprazolam and should be avoided.

Sources

• FDA Drug Labeling (Alprazolam): FDA Drug Labeling via OpenFDA (open.fda.gov) – Complete prescribing information including contraindications and drug interactions
• FDA Drug Labeling (Clarithromycin): FDA Drug Labeling via OpenFDA (open.fda.gov)
• FDA Drug Labeling (Fluoxetine): FDA Drug Labeling via OpenFDA (open.fda.gov)
• FDA Drug Labeling (Ketoconazole): FDA Drug Labeling via OpenFDA (open.fda.gov)
• CDC WONDER Database: Multiple Cause of Death data, 2015–2022, benzodiazepine-involved overdose deaths
• NIH National Library of Medicine: CYP3A4 enzyme pathway and benzodiazepine metabolism – PMID references available via PubMed (pubmed.ncbi.nlm.nih.gov)
• DEA Orange Book: Drug schedules and abuse potential (alprazolam is Schedule IV)
• SAMHSA (Substance Abuse and Mental Health Services Administration): Benzodiazepine misuse and overdose prevention guidance
• Alprazolam and Clarithromycin interaction
• Alprazolam and Opioids interaction
• Alprazolam and Fluoxetine interaction

Check Your Full Medication List Now

If you take alprazolam or are considering starting it, the safest step is to review all your current and anticipated medications with a comprehensive drug interaction checker. At checkdruginteractions.com, you can enter your complete medication list and instantly see all potential interactions ranked by severity, with FDA data and evidence-based guidance on how to manage them safely. Don't rely on memory or assumptions—use our free interaction checker to ensure your medication regimen is safe before you start a new drug. Your life may depend on it.